Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Advances in Pharmacology (San Diego, Calif.)|May 26, 2023
The roles of eicosanoids in myocardial diseasesZuowen He, Dao Wen WangMolecules (Basel, Switzerland)|June 24, 2022
CYP450 Epoxygenase Metabolites, Epoxyeicosatrienoic Acids, as Novel Anti-Inflammatory MediatorsZeqi Shi, Zuowen He, Dao Wen WangPharmacology & Therapeutics|July 23, 2023
Vasospastic angina: Past, present, and futureZuowen He, Xin Xu, Qu Zhao, et al.Hypertension (Dallas, Tex. : 1979)|December 3, 2019
Adenosine 2A Receptor Activation Contributes to Ang II-Induced Aortic Remodeling by Promoting Macrophage RetentionZuowen He, Xizhen Xu, Chen Chen, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 27, 2022
Epoxyeicosatrienoic acid: A potential therapeutic target of heart failure with preserved ejection fractionMin Zhang, Hongyang Shu, Chen Chen, et al.Cardiovascular Research|January 26, 2015
Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin IIZuowen He, Xu Zhang, Chen Chen, et al.Frontiers in Pharmacology|August 28, 2020
Trimetazidine Inhibits Renal Tubular Epithelial Cells to Mesenchymal Transition in Diabetic Rats via Upregulation of Sirt1Yong Yang, Yong Wang, Zuowen He, et al.Journal of Lipid Research|May 31, 2017
CYP2J2 metabolites, epoxyeicosatrienoic acids, attenuate Ang II-induced cardiac fibrotic response by targeting Gα12/13Zuowen He, Yong Yang, Zheng Wen, et al.International Journal of Cardiology|November 8, 2021
Single-case metanalysis of fat embolism syndromeZuowen He, Zeqi Shi, Chenze Li, et al.Journal of Cellular Physiology|January 29, 2015
Epoxyeicosatrienoic acids regulate macrophage polarization and prevent LPS-induced cardiac dysfunctionMeiyan Dai, Lujin Wu, Zuowen He, et al.Pageof 2